BioLife Solutions Inc (BLFS)

Exchange
NASDAQ
Symbol
BLFS
Sector
Life Sciences
Industry
Electromedical & Electrotherapeutic Apparatus
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the gene and cell therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company is headquartered in Bothell, Washington.
Country
USA

Stock price

At close: November 22, 2024

  • Open
    25.73
  • High
    26.06
  • Low
    25.10
  • Close
    26.01
  • Volume
    585,681

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
2.46
Receivables turnover
7.65
Payables turnover
15.38
Working capital turnover
1.82
Days of inventory on hand (DOH)
148.62
Days of sales outstanding (DSO)
47.69
Number of days of payables
23.74
Fixed asset turnover
6.77
Total asset turnover
0.35
 Liquidity ratios
Current ratio
2.86
Quick ratio
1.67
Cash ratio
1.23
Cash conversion cycle
172.58
 Solvency ratios
Debt-to-assets ratio
0.04
Debt-to-capital ratio
0.05
Debt-to-equity ratio
0.05
Financial leverage ratio
1.22
Interest coverage
-5,447.92
 Profitability ratios
Gross profit margin
25.26%
Operating profit margin
-49.60%
Pretax margin
-46.40%
Net profit margin
-46.52%
Operating return on assets (Operating ROA)
-17.16%
Return on assets (ROA)
-16.10%
Return on total capital
-19.90%
Return on equity (ROE)
-19.67%